Unknown

Dataset Information

0

Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III.


ABSTRACT:

Background

Mucopolysaccharidosis type III (MPS III) is an autosomal recessive lysosomal storage disorder characterised by progressive neurocognitive deterioration. MPS III subtypes are clinically indistinguishable, with a wide range of symptoms and variable severity. The natural history of this disorder within an Asian population has not yet been extensively studied. This study investigated the natural history of Korean patients with MPS III.

Methods

Thirty-four patients from 31 families diagnosed with MPS III from January 1997 to May 2020 in Samsung Medical Centre were enrolled. Clinical, molecular, and biochemical characteristics were retrospectively collected from the patients' medical records and via interviews.

Results

18 patients had MPS IIIA, 14 had IIIB, and two had IIIC. Twenty (58.9%) patients were male. Mean age at symptom onset was 2.8 ± 0.8 years and at diagnosis was 6.3 ± 2.2 years. All patients with MPS IIIA and IIIB were classified into the rapidly progressing (RP) phenotype. The most common symptom at diagnosis was language retardation (88.2%), followed by motor retardation (76.5%), general retardation (64.7%), and hyperactivity (41.2%). Language retardation was more predominant in IIIA, and motor retardation was more predominant in IIIB. The mean age of the 13 deceased patients at the time of the study was 14.4 ± 4.1 years. The age at diagnosis and lag time were significantly older and longer in the non-survivor group compared with the survivor group (p = 0.029 and 0.045, respectively). Genetic analysis was performed in 24 patients with MPS III and identified seven novel variants and three hot spots.

Conclusion

This study is the first to analyse the genetic and clinical characteristics of MPS III patients in Korea. Better understanding of the natural history of MPS III might allow early diagnosis and timely management of the disease and evaluation of treatment outcomes in future clinical trials for MPS III.

SUBMITTER: Kim MS 

PROVIDER: S-EPMC9145712 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III.

Kim Min-Sun MS   Yang Aram A   Noh Eu-Seon ES   Kim Chiwoo C   Bae Ga Young GY   Lim Han Hyuk HH   Park Hyung-Doo HD   Cho Sung Yoon SY   Jin Dong-Kyu DK  

Journal of personalized medicine 20220421 5


<h4>Background</h4>Mucopolysaccharidosis type III (MPS III) is an autosomal recessive lysosomal storage disorder characterised by progressive neurocognitive deterioration. MPS III subtypes are clinically indistinguishable, with a wide range of symptoms and variable severity. The natural history of this disorder within an Asian population has not yet been extensively studied. This study investigated the natural history of Korean patients with MPS III.<h4>Methods</h4>Thirty-four patients from 31 f  ...[more]

Similar Datasets

| S-EPMC6567572 | biostudies-literature
| S-EPMC4769976 | biostudies-literature
| S-EPMC3925123 | biostudies-literature
| S-EPMC9248211 | biostudies-literature
| S-EPMC6498678 | biostudies-literature
| S-EPMC2757673 | biostudies-literature
| S-EPMC8436764 | biostudies-literature
| S-EPMC5987665 | biostudies-literature
| S-EPMC10228206 | biostudies-literature
| S-EPMC8141134 | biostudies-literature